Skip to content

Exploring Blood Biomarkers in patients with Hearing Loss

Exploring Blood Biomarkers in patients with Hearing Loss - Exploring Biomarkers of Hearing Loss

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057419
Enrollment
100
Registered
2025-03-27
Start date
2024-09-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hearing loss, vertigo

Interventions

Blood test

Sponsors

National Institute of Sensory Organ, National Hospital Organization of Tokyo Medical Center Clinical Research Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with inner ear disorders such as sudden hearing loss, Meniere's disease, presbycusis, vestibular neuritis, etc. who visit outpatient clinic in department of otorhinolaryngology in National institute of sensory organ Tokyo medical center

Exclusion criteria

Exclusion criteria: under 18 years of age, unconscious persons, etc.

Design outcomes

Primary

MeasureTime frame
Correlation between hearing test (pure tone audiometry) and biomarkers

Countries

Japan

Contacts

Public ContactSho Kanzaki

National institute of Sensory Organ, National Hospital Organization of Tokyo Medical Center Laboratory of Auditory Disorders, Auditory and Balance Research Division

shokanza@yahoo.co.jp0353633827

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026